SH

Srilakshmi Hanumanatha

Active Director Designated Partner DIN 11626999
DIN 11626999 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Srilakshmi Hanumanatha

Data last updated:

Srilakshmi Hanumanatha is a Designated Partner at Vi2 Life Sciences Llp (since 2026) and Designated Partner at Qiksol Pharma Llp (since 2026).

DIN 11626999
Primary Designation Designated Partner
First Appointment 24 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Jul 20262026Active
Designated Partner24 Mar 20262026Active

Board colleagues of Srilakshmi Hanumanatha

NameDINCompanyDesignation
Vinutha Hanumanthareddy09611502Vi2 Life Sciences LlpDesignated Partner
Kuldeep Kuber Bhokare11626998Qiksol Pharma LlpDesignated Partner
Parul Chetan Parekh06512733Qiksol Pharma LlpDesignated Partner
Sanjay Boldhane11626997Qiksol Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Qiksol Pharma Llp
Vi2 Life Sciences Llp
Premium access

Shareholding and investment profile for Srilakshmi Hanumanatha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srilakshmi Hanumanatha

Srilakshmi Hanumanatha currently holds 2 directorships: Vi2 Life Sciences Llp (Designated Partner, since 21 Jul 2026); Qiksol Pharma Llp (Designated Partner, since 24 Mar 2026).

Srilakshmi Hanumanatha was first appointed on 24 Mar 2026 as Designated Partner at Qiksol Pharma Llp.

The current boards of Srilakshmi Hanumanatha's companies include Vinutha Hanumanthareddy (Vi2 Life Sciences Llp), Kuldeep Kuber Bhokare (Qiksol Pharma Llp), Parul Chetan Parekh (Qiksol Pharma Llp), Sanjay Boldhane (Qiksol Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available